[1] Article Title: Comprehensive review of congenital myasthenic syndromes from around the world
	•	Line(s): 3
	•	Section: Title Page
	•	Quote(s): Comprehensive review of congenital myasthenic syndromes from around the world

⸻

[2] Publication Year: 2023
	•	Line(s): 7
	•	Section: Title Page
	•	Quote(s): Journal of Neurology (2023)

⸻

[3] Region: Global
	•	Line(s): 3, 61–65
	•	Section: Title, Abstract
	•	Quote(s): from around the world; We aimed to analyze the global landscape of CMS studies

⸻

[4] Country: Multiple (Global review)
	•	Line(s): 125–135
	•	Section: Methods
	•	Quote(s): All relevant studies of CMS cases in humans published in English from January 2000 to September 2021 were included

⸻

[5] Coverage Area: International
	•	Line(s): 65, 135
	•	Section: Abstract, Methods
	•	Quote(s): the global landscape; CMS cases in humans published in English

⸻

[6] Study Design: Systematic review
	•	Line(s): 125–126
	•	Section: Methods
	•	Quote(s): We performed a systematic review using PubMed

⸻

[7] Study Population: CMS patients across all reported cases from eligible studies
	•	Line(s): 125–130
	•	Section: Methods
	•	Quote(s): All relevant studies of CMS cases in humans… were included in this systematic review.

⸻

[8] Population Characteristics: All ages; mixed demographics depending on original studies
	•	Line(s): 155–158
	•	Section: Results
	•	Quote(s): The ages at onset ranged widely from the neonatal period to adulthood.

⸻

[9] Data Source Type: Published clinical reports / case series
	•	Line(s): 125–135
	•	Section: Methods
	•	Quote(s): We performed a systematic review using PubMed…

⸻

[10] Data Source Details:
	•	Line(s): 125–135
	•	Section: Methods
	•	Quote(s): We performed a systematic review using PubMed… published in English from January 2000 to September 2021.

⸻

[11] Study Timeline Type: Neither
	•	Line(s): 125–130
	•	Section: Methods
	•	Quote(s): All relevant studies of CMS cases in humans published in English from January 2000 to September 2021

⸻

[12] Number of Sites: 
	•	Line(s): 125–130
	•	Section: Methods
	•	Quote(s): All relevant studies…

⸻

[13] Study Start Year: NA
	•	Line(s): 125–130
	•	Section: Methods
	•	Quote(s): published in English from January 2000…

⸻

[14] Study End Year: NA
	•	Line(s): 125–130
	•	Section: Methods
	•	Quote(s): …to September 2021

⸻

[15] Main Ethnicity: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Congenital Myasthenic Syndromes (CMS)
	•	Line(s): 3, 60
	•	Section: Title, Abstract
	•	Quote(s): Comprehensive review of congenital myasthenic syndromes; CMS are heterogeneous inherited disorders

⸻

[18] Diagnosis Method: Genetic testing, clinical evaluation
	•	Line(s): 60–63
	•	Section: Abstract
	•	Quote(s): diagnosed using clinical symptoms and confirmed by genetic testing

⸻

[19] Diagnosis Criteria Details: Based on clinical symptoms and genetic confirmation
	•	Line(s): 60–63
	•	Section: Abstract
	•	Quote(s): CMS are… characterized by fatigable muscle weakness and confirmed by genetic testing.

⸻

[20] Disease Phase: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[21] Cohort Age Group: Mixed
	•	Line(s): 157–158
	•	Section: Results
	•	Quote(s): The ages at onset ranged widely from the neonatal period to adulthood.

⸻

[22] Female % in Cohort: NR
	•	Line(s): NR
	•	Section: NR
	•	Quote(s): NR

⸻

[23] Consanguinity: NR
	•	Line(s): 349–350
	•	Section: Results
	•	Quote(s): Consanguinity was reported in 1325 families (38.7%) out of 3421 families